ACMG Carrier Screening Guidelines: Falling Short On Equity and Inclusion
By Katie Stoll and Robert Resta,
The DNA Exchange
| 07. 26. 2021
The American College of Medical Genetics and Genomics (ACMG) recently published a new Clinical Practice Resource that they proclaim recommends an “equitable approach for offering carrier screening to all individuals during pregnancy or preconception.”
We recognize the drawbacks of a screening program based solely on reported ancestry or ethnicity. And we understand that ensuring the same standard of carrier screening is available to all patients regardless of race or ethnic background addresses an important equity concern. However, the ACMG guidelines fall short in several areas:
- Addressing the benefits of carrier screening
- Questionable criteria for determining the severity of the included conditions
- A limited definition of inclusivity
- What choice patients should have in which conditions are or are not included in their personal screening.
The ACMG guidance is broad, calling for offering sequence-based population carrier screening for 113 genetic conditions to all patients who are pregnant or considering pregnancy. The rationale for expanded carrier screening according to the guideline is to allow for informed reproductive decisions. Specifically ACMG states that “reproductive decision making is the established metric for clinical utility of... see more
Related Articles
By Kudrat Wadhwa , The Verge | 06.14.2022
When Arianna Huhn experienced complications with her first pregnancy, she signed up for a clinical trial, one that required her to submit family DNA samples for research. Her parents, Gail and George Fogelman, agreed. But shortly after, they asked her...
By Mohana Basu , The Print | 05.31.2022
New Delhi: For centuries, matching janampatris and kundalis, or natal charts, has been an important aspect of the matchmaking process in India. It has been said to determine whether a couple is well-suited. But couples these days are opting for...
By Carey Goldberg, Bloomberg | 05.26.2022
Photo by Warren Umoh on Unsplash
Simone Collins knew she was pregnant the moment she answered the phone. She was on her sixth round of in vitro fertilization treatments and had grown used to staffers at Main Line Fertility starting...
By Laura Hercher, Scientific American | 06.01.2022
In clinics today, fertility patients using in vitro fertilization (IVF) are routinely advised to pay for an expensive supplemental test called preimplantation genetic testing for aneuploidy (PGT-A), in which a handful of cells are removed from the embryo to examine...